Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection.
Identifieur interne : 001355 ( Main/Corpus ); précédent : 001354; suivant : 001356Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection.
Auteurs : Ayse Basak Engin ; Evren Doruk Engin ; Atilla EnginSource :
- Environmental toxicology and pharmacology [ 1872-7077 ] ; 2020.
English descriptors
- KwdEn :
- Antiviral Agents (pharmacology), Betacoronavirus (MeSH), COVID-19 (MeSH), Coronavirus Infections (drug therapy), Coronavirus Infections (metabolism), Gastrointestinal Diseases (metabolism), Gastrointestinal Diseases (virology), Humans (MeSH), N-Acetylneuraminic Acid (metabolism), Pandemics (MeSH), Pneumonia, Viral (drug therapy), Pneumonia, Viral (metabolism), SARS-CoV-2 (MeSH), Virus Attachment (MeSH).
- MESH :
- chemical , metabolism : N-Acetylneuraminic Acid.
- chemical , pharmacology : Antiviral Agents.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- metabolism : Coronavirus Infections, Gastrointestinal Diseases, Pneumonia, Viral.
- virology : Gastrointestinal Diseases.
- Betacoronavirus, COVID-19, Humans, Pandemics, SARS-CoV-2, Virus Attachment.
Abstract
Recent analysis concerning the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)- angiotensin converting enzyme (ACE) receptor interaction in enterocytes, the definition of gut-lung axis, as well as the molecular basis of sialic acid-related dual recognition concept in gastrointestinal SARS-CoV-2 infection, have brought a new perspective to potential therapeutic targets. In this review evolving research and clinical data on gastrointestinal SARS-CoV-2 infection are discussed in the context of viral fusion and entry mechanisms, focusing on the different triggers used by coronaviruses. Furthermore, it is emphasized that the viral spike protein is prevented from binding gangliosides, which are composed of a glycosphingolipid with one or more sialic acids, in the presence of chloroquine or hydroxychloroquine. In gastrointestinal SARS-CoV-2 infection the efficiency of these repositioned drugs is debated.
DOI: 10.1016/j.etap.2020.103436
PubMed: 32562764
PubMed Central: PMC7833001
Links to Exploration step
pubmed:32562764Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection.</title><author><name sortKey="Engin, Ayse Basak" sort="Engin, Ayse Basak" uniqKey="Engin A" first="Ayse Basak" last="Engin">Ayse Basak Engin</name><affiliation><nlm:affiliation>Gazi University, Faculty of Pharmacy, Department of Toxicology, Ankara, Turkey. Electronic address: abengin@gmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Engin, Evren Doruk" sort="Engin, Evren Doruk" uniqKey="Engin E" first="Evren Doruk" last="Engin">Evren Doruk Engin</name><affiliation><nlm:affiliation>Ankara University, Biotechnology Institute, Gumusdere Campus, Kecioren, Ankara, Turkey.</nlm:affiliation></affiliation></author><author><name sortKey="Engin, Atilla" sort="Engin, Atilla" uniqKey="Engin A" first="Atilla" last="Engin">Atilla Engin</name><affiliation><nlm:affiliation>Gazi University, Faculty of Medicine, Department of General Surgery, Ankara, Turkey.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32562764</idno><idno type="pmid">32562764</idno><idno type="doi">10.1016/j.etap.2020.103436</idno><idno type="pmc">PMC7833001</idno><idno type="wicri:Area/Main/Corpus">001355</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001355</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection.</title><author><name sortKey="Engin, Ayse Basak" sort="Engin, Ayse Basak" uniqKey="Engin A" first="Ayse Basak" last="Engin">Ayse Basak Engin</name><affiliation><nlm:affiliation>Gazi University, Faculty of Pharmacy, Department of Toxicology, Ankara, Turkey. Electronic address: abengin@gmail.com.</nlm:affiliation></affiliation></author><author><name sortKey="Engin, Evren Doruk" sort="Engin, Evren Doruk" uniqKey="Engin E" first="Evren Doruk" last="Engin">Evren Doruk Engin</name><affiliation><nlm:affiliation>Ankara University, Biotechnology Institute, Gumusdere Campus, Kecioren, Ankara, Turkey.</nlm:affiliation></affiliation></author><author><name sortKey="Engin, Atilla" sort="Engin, Atilla" uniqKey="Engin A" first="Atilla" last="Engin">Atilla Engin</name><affiliation><nlm:affiliation>Gazi University, Faculty of Medicine, Department of General Surgery, Ankara, Turkey.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Environmental toxicology and pharmacology</title><idno type="eISSN">1872-7077</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (pharmacology)</term><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (metabolism)</term><term>Gastrointestinal Diseases (metabolism)</term><term>Gastrointestinal Diseases (virology)</term><term>Humans (MeSH)</term><term>N-Acetylneuraminic Acid (metabolism)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (metabolism)</term><term>SARS-CoV-2 (MeSH)</term><term>Virus Attachment (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>N-Acetylneuraminic Acid</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Coronavirus Infections</term><term>Gastrointestinal Diseases</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Gastrointestinal Diseases</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Humans</term><term>Pandemics</term><term>SARS-CoV-2</term><term>Virus Attachment</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Recent analysis concerning the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)- angiotensin converting enzyme (ACE) receptor interaction in enterocytes, the definition of gut-lung axis, as well as the molecular basis of sialic acid-related dual recognition concept in gastrointestinal SARS-CoV-2 infection, have brought a new perspective to potential therapeutic targets. In this review evolving research and clinical data on gastrointestinal SARS-CoV-2 infection are discussed in the context of viral fusion and entry mechanisms, focusing on the different triggers used by coronaviruses. Furthermore, it is emphasized that the viral spike protein is prevented from binding gangliosides, which are composed of a glycosphingolipid with one or more sialic acids, in the presence of chloroquine or hydroxychloroquine. In gastrointestinal SARS-CoV-2 infection the efficiency of these repositioned drugs is debated.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32562764</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7077</ISSN><JournalIssue CitedMedium="Internet"><Volume>79</Volume><PubDate><Year>2020</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Environmental toxicology and pharmacology</Title><ISOAbbreviation>Environ Toxicol Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection.</ArticleTitle><Pagination><MedlinePgn>103436</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1382-6689(20)30112-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.etap.2020.103436</ELocationID><Abstract><AbstractText>Recent analysis concerning the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)- angiotensin converting enzyme (ACE) receptor interaction in enterocytes, the definition of gut-lung axis, as well as the molecular basis of sialic acid-related dual recognition concept in gastrointestinal SARS-CoV-2 infection, have brought a new perspective to potential therapeutic targets. In this review evolving research and clinical data on gastrointestinal SARS-CoV-2 infection are discussed in the context of viral fusion and entry mechanisms, focusing on the different triggers used by coronaviruses. Furthermore, it is emphasized that the viral spike protein is prevented from binding gangliosides, which are composed of a glycosphingolipid with one or more sialic acids, in the presence of chloroquine or hydroxychloroquine. In gastrointestinal SARS-CoV-2 infection the efficiency of these repositioned drugs is debated.</AbstractText><CopyrightInformation>Copyright © 2020 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Engin</LastName><ForeName>Ayse Basak</ForeName><Initials>AB</Initials><AffiliationInfo><Affiliation>Gazi University, Faculty of Pharmacy, Department of Toxicology, Ankara, Turkey. Electronic address: abengin@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engin</LastName><ForeName>Evren Doruk</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Ankara University, Biotechnology Institute, Gumusdere Campus, Kecioren, Ankara, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Engin</LastName><ForeName>Atilla</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gazi University, Faculty of Medicine, Department of General Surgery, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Environ Toxicol Pharmacol</MedlineTA><NlmUniqueID>9612020</NlmUniqueID><ISSNLinking>1382-6689</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>GZP2782OP0</RegistryNumber><NameOfSubstance UI="D019158">N-Acetylneuraminic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="N">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019158" MajorTopicYN="N">N-Acetylneuraminic Acid</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053585" MajorTopicYN="N">Virus Attachment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2</Keyword><Keyword MajorTopicYN="N">Chloroquine</Keyword><Keyword MajorTopicYN="N">Faecal-oral route</Keyword><Keyword MajorTopicYN="N">Gut-lung axis</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Sialic acid</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>06</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>06</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32562764</ArticleId><ArticleId IdType="pii">S1382-6689(20)30112-5</ArticleId><ArticleId IdType="doi">10.1016/j.etap.2020.103436</ArticleId><ArticleId IdType="pmc">PMC7833001</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Virol. 2014 Jan;88(2):1293-307</Citation><ArticleIdList><ArticleId IdType="pubmed">24227843</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2015 Jul;89(14):7202-13</Citation><ArticleIdList><ArticleId IdType="pubmed">25926653</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Jun;55(6):105980</Citation><ArticleIdList><ArticleId IdType="pubmed">32294495</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):E8508-E8517</Citation><ArticleIdList><ArticleId IdType="pubmed">28923942</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gastroenterol Hepatol. 2020 May;35(5):744-748</Citation><ArticleIdList><ArticleId IdType="pubmed">32215956</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Aug 30;8(8):e72942</Citation><ArticleIdList><ArticleId IdType="pubmed">24023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2013 Dec;11(12):836-48</Citation><ArticleIdList><ArticleId IdType="pubmed">24217413</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Gastroenterol Hepatol. 2020 Jul;18(8):1663-1672</Citation><ArticleIdList><ArticleId IdType="pubmed">32278065</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Dec;82(23):11985-91</Citation><ArticleIdList><ArticleId IdType="pubmed">18786990</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Feb;69(2):889-95</Citation><ArticleIdList><ArticleId IdType="pubmed">7815557</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation><ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Exp Med Biol. 1998;440:557-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9782329</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Struct Mol Biol. 2019 Dec;26(12):1151-1157</Citation><ArticleIdList><ArticleId IdType="pubmed">31792450</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430</Citation><ArticleIdList><ArticleId IdType="pubmed">32145190</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Jun 1;101(22):8455-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15150417</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Aug 20;9(8):e104751</Citation><ArticleIdList><ArticleId IdType="pubmed">25140899</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 1992 Jun 4;357(6377):417-20</Citation><ArticleIdList><ArticleId IdType="pubmed">1350661</ArticleId></ArticleIdList></Reference><Reference><Citation>Cureus. 2020 Mar 26;12(3):e7422</Citation><ArticleIdList><ArticleId IdType="pubmed">32351807</ArticleId></ArticleIdList></Reference><Reference><Citation>Antivir Chem Chemother. 2006;17(5):275-84</Citation><ArticleIdList><ArticleId IdType="pubmed">17176632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Feb;79(3):1743-52</Citation><ArticleIdList><ArticleId IdType="pubmed">15650199</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 May;55(5):105960</Citation><ArticleIdList><ArticleId IdType="pubmed">32251731</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2011 Jul;55(7):3091-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21518836</ArticleId></ArticleIdList></Reference><Reference><Citation>Sci Immunol. 2020 May 13;5(47):</Citation><ArticleIdList><ArticleId IdType="pubmed">32404436</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2003 Nov 27;426(6965):450-4</Citation><ArticleIdList><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2014 Aug 14;10(8):e1004320</Citation><ArticleIdList><ArticleId IdType="pubmed">25122212</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2020 Jun;69(6):1141-1143</Citation><ArticleIdList><ArticleId IdType="pubmed">32102928</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2020 Jun;69(6):1002-1009</Citation><ArticleIdList><ArticleId IdType="pubmed">32213556</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2012 Jun;4(6):1011-33</Citation><ArticleIdList><ArticleId IdType="pubmed">22816037</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Virol. 1992;125(1-4):193-204</Citation><ArticleIdList><ArticleId IdType="pubmed">1642550</ArticleId></ArticleIdList></Reference><Reference><Citation>Expert Rev Mol Med. 2010 Sep 01;12:e27</Citation><ArticleIdList><ArticleId IdType="pubmed">20807455</ArticleId></ArticleIdList></Reference><Reference><Citation>Protein Sci. 2014 May;23(5):603-17</Citation><ArticleIdList><ArticleId IdType="pubmed">24519901</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Oct 01;9(10):e109180</Citation><ArticleIdList><ArticleId IdType="pubmed">25271834</ArticleId></ArticleIdList></Reference><Reference><Citation>Intensive Care Med. 2020 Apr;46(4):586-590</Citation><ArticleIdList><ArticleId IdType="pubmed">32125455</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Mar 5;382(10):929-936</Citation><ArticleIdList><ArticleId IdType="pubmed">32004427</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Virus Res. 2006;66:193-292</Citation><ArticleIdList><ArticleId IdType="pubmed">16877062</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Feb;81(3):1261-73</Citation><ArticleIdList><ArticleId IdType="pubmed">17093189</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2020 Jul;159(1):81-95</Citation><ArticleIdList><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2020 Jun;69(6):997-1001</Citation><ArticleIdList><ArticleId IdType="pubmed">32241899</ArticleId></ArticleIdList></Reference><Reference><Citation>Top Curr Chem. 2015;367:1-28</Citation><ArticleIdList><ArticleId IdType="pubmed">23873408</ArticleId></ArticleIdList></Reference><Reference><Citation>Glycobiology. 1992 Feb;2(1):25-40</Citation><ArticleIdList><ArticleId IdType="pubmed">1550987</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2020 Mar 17;94(7):</Citation><ArticleIdList><ArticleId IdType="pubmed">31996437</ArticleId></ArticleIdList></Reference><Reference><Citation>Dig Liver Dis. 2020 Jul;52(7):700-701</Citation><ArticleIdList><ArticleId IdType="pubmed">32423849</ArticleId></ArticleIdList></Reference><Reference><Citation>Indian Pediatr. 2020 Apr 12;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32279064</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Biol Cell. 2010 Nov 15;21(22):3838-52</Citation><ArticleIdList><ArticleId IdType="pubmed">20861307</ArticleId></ArticleIdList></Reference><Reference><Citation>Gut. 2020 Jun;69(6):973-974</Citation><ArticleIdList><ArticleId IdType="pubmed">32273292</ArticleId></ArticleIdList></Reference><Reference><Citation>J Gen Virol. 2000 Feb;81(Pt 2):489-96</Citation><ArticleIdList><ArticleId IdType="pubmed">10644848</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2003 Nov;77(21):11846-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14557669</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2011 Sep 12;8:435</Citation><ArticleIdList><ArticleId IdType="pubmed">21910859</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1996 Aug;70(8):5634-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8764078</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 2016 Oct 21;60(11):6532-6539</Citation><ArticleIdList><ArticleId IdType="pubmed">27550352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2020 Jul;159(1):53-61</Citation><ArticleIdList><ArticleId IdType="pubmed">32353371</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2005 Aug 22;2:69</Citation><ArticleIdList><ArticleId IdType="pubmed">16115318</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2011 Jan;85(2):873-82</Citation><ArticleIdList><ArticleId IdType="pubmed">21068237</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2016 Aug;14(8):523-34</Citation><ArticleIdList><ArticleId IdType="pubmed">27344959</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 1997 Jan;24(1):55-60</Citation><ArticleIdList><ArticleId IdType="pubmed">9002011</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2017 Jan;15(1):55-63</Citation><ArticleIdList><ArticleId IdType="pubmed">27694885</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2020 Mar 27;367(6485):1444-1448</Citation><ArticleIdList><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>BJGP Open. 2020 Jun 23;4(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">32398343</ArticleId></ArticleIdList></Reference><Reference><Citation>Aliment Pharmacol Ther. 2020 May;51(9):843-851</Citation><ArticleIdList><ArticleId IdType="pubmed">32222988</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ Toxicol Pharmacol. 2020 Aug;78:103411</Citation><ArticleIdList><ArticleId IdType="pubmed">32422280</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Gastroenterol. 2020 May;115(5):766-773</Citation><ArticleIdList><ArticleId IdType="pubmed">32287140</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12543-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16116101</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochim Biophys Acta. 2008 Dec;1778(12):2765-74</Citation><ArticleIdList><ArticleId IdType="pubmed">18721794</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2008;454:319-29</Citation><ArticleIdList><ArticleId IdType="pubmed">19057868</ArticleId></ArticleIdList></Reference><Reference><Citation>Viruses. 2013 Jul 26;5(8):1924-33</Citation><ArticleIdList><ArticleId IdType="pubmed">23896748</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Aug;56(2):106020</Citation><ArticleIdList><ArticleId IdType="pubmed">32405156</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2008 Nov 25;381(2):215-21</Citation><ArticleIdList><ArticleId IdType="pubmed">18814896</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 2020 Jun;41(6):745-746</Citation><ArticleIdList><ArticleId IdType="pubmed">32131906</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 24;361(9371):1761-6</Citation><ArticleIdList><ArticleId IdType="pubmed">12781533</ArticleId></ArticleIdList></Reference><Reference><Citation>Glycoconj J. 2006 Feb;23(1-2):51-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16575522</ArticleId></ArticleIdList></Reference><Reference><Citation>Methods Mol Biol. 2020;2132:483-545</Citation><ArticleIdList><ArticleId IdType="pubmed">32306355</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1988 Dec;62(12):4686-90</Citation><ArticleIdList><ArticleId IdType="pubmed">3184275</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Jun 13;395(10240):1820</Citation><ArticleIdList><ArticleId IdType="pubmed">32511943</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2012 Jul 25;487(7408):477-81</Citation><ArticleIdList><ArticleId IdType="pubmed">22837003</ArticleId></ArticleIdList></Reference><Reference><Citation>Arab J Gastroenterol. 2020 Mar;21(1):3-8</Citation><ArticleIdList><ArticleId IdType="pubmed">32253172</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 May 12;323(18):1843-1844</Citation><ArticleIdList><ArticleId IdType="pubmed">32159775</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2020 Jul;92(7):833-840</Citation><ArticleIdList><ArticleId IdType="pubmed">32243607</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Rheumatol. 1994 Mar;33(3):235-9</Citation><ArticleIdList><ArticleId IdType="pubmed">8156285</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2003 Nov;3(11):722-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14592603</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Pharmacol. 2020 Jul;60(7):808-814</Citation><ArticleIdList><ArticleId IdType="pubmed">32434282</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2006 Feb;6(2):67-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16439323</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2020 Feb 14;94(5):</Citation><ArticleIdList><ArticleId IdType="pubmed">31826992</ArticleId></ArticleIdList></Reference><Reference><Citation>Gastroenterology. 2020 May;158(6):1831-1833.e3</Citation><ArticleIdList><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2006 Mar;80(5):2326-36</Citation><ArticleIdList><ArticleId IdType="pubmed">16474139</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001355 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001355 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= pubmed:32562764
|texte= Dual function of sialic acid in gastrointestinal SARS-CoV-2 infection.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32562764" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |